Robert F. Kennedy Jr. would retain legal fees earned from litigation against drugmaker Merck if he is confirmed as President Donald Trump's secretary of the U.S. Department of Health and Human Services,
Robert F. Kennedy, Jr, the nominee for Secretary of HHS, has made promises about the status of his stake in anti-vaccine nonprofits and notable pharma companies as his confirmation hearing approaches.
Robert F. Kennedy Jr., HHS secretary nominee, faces criticism for financial ties to vaccine lawsuits, raising ethical concerns over regulatory impartiality.
A conservative group founded by former Vice President Mike Pence is urging Republicans to reject Robert F. Kennedy Jr. as Health and Human Services Secretary, citing his support for abortion access—as some GOP senators who have expressed concerns about his controversial vaccine views have not said whether they will vote to confirm Kennedy.
Robert F. Kennedy Jr. is distancing himself from his anti-vaccine work as he seeks to become the leader of the nation’s top health agency under President Donald Trump, according to government ethics documents released Wednesday.
A coalition opposing the nominee for health secretary includes faculty members from leading U.S. academic institutions, including public health schools at Yale and Harvard.
The Senate Finance Committee will meet on Jan. 29 to discuss the confirmation of RFK Jr., whose stances on vaccines and abortion have raised questions from Democrats and Republicans alike.